Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Burow Kristina Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.
Txns: Disposed of 1,600,000 shares @ $0
06/09/2023 4 Burow Kristina (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
06/08/2023 4 Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.
Txns: Granted 16,532 options to buy @ $34.33, valued at $567.5k
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/02/2022 4 Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.
Txns: Granted 10,391 options to buy @ $55.58, valued at $577.5k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Burow Kristina (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Granted 28,000 options to buy @ $4.75, valued at $133k
08/09/2021 4 ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.
Txns: Disposed of 701,250 options to buy @ $0
08/03/2021 4 ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.
Txns: Bought 1,600,000 shares @ $10, valued at $16M
Acquired 650,000 shares @ $10, valued at $6.5M
07/27/2021 3 ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on DA32 Life Science Tech Acquisition Corp.
07/20/2021 4 ARCH Venture Partners X, LLC (10% Owner) has filed a Form 4 on Erasca, Inc.
Txns: Converted 5,527,777 shares @ $0
Converted 2,100,000 preferred shares @ $0
Converted 3,400,000 preferred shares @ $0
Converted 1,133,333 preferred shares @ $0
07/15/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2021 4 Burow Kristina (Director) has filed a Form 4 on Unity Biotechnology, Inc.
Txns: Granted 25,000 options to buy @ $4.18, valued at $104.5k
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2021 4 Burow Kristina (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns: Granted 7,800 options to buy @ $26.78, valued at $208.9k
05/25/2021 4 Burow Kristina (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $4.07, valued at $67.2k
04/02/2021 4 Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.
Txns: Disposed of 200,000 shares @ $0
Disposed of 200,000 shares @ $0
Acquired 2,011 shares @ $0
03/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
10/13/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/22/2020 4 Burow Kristina (Director) has filed a Form 4 on Unity Biotechnology, Inc.
Txns: Granted 25,000 options to buy @ $9.14, valued at $228.5k
06/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy